This randomised , blinded , placebo-controlled trial in moderate/severe COPD patients compared once-daily glycopyrronium ( GLY ) @g , once-daily tiotropium ( TIO ) @g or placebo ( PLA ) , when combined with salmeterol/fluticasone propionate ( SAL/FP ) @/@g twice daily .